Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

Clinical trial NCT07516418 · RECRUITING

Trial details

NCT number: NCT07516418
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)Influenza A(H5N1)

Start date: 2026-04-15
Primary completion: 2027-04-04
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.